Teva Pharmaceutical: Clinical Trials & FDA Approval Profile
Teva Pharmaceutical (Tel Aviv, IL / Parsippany, NJ) sponsors 31 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 6 active protocols (1 recruiting now), 17 completed protocols, and 85 all-time original FDA Drugs@FDA NDA and BLA approvals.